임상간호연구 (Journal of Korean Clinical Nursing Research)

  • 제23권1호
  • /
  • Pages.120-129
  • /
  • 2017
  • /
  • 1598-9186(pISSN)
  • /
  • 2287-3694(eISSN)
병원간호사회 (Hospital Nurses Association)
권호 표지
DOI QR코드

DOI QR Code

항호르몬요법을 받는 유방암 여성의 갱년기 증상과 연관 변인간의 분석

Menopausal Symptoms and Associated Factors in Breast Cancer Patients Receiving Hormone Therapy

  • 투고 : 2017.01.10
  • 심사 : 2017.02.16
  • 발행 : 2017.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: The purpose of this study was to identify the degree of menopause symptoms and associated factors in patients with breast cancer who were receiving hormone therapy. Methods: Data were collected with questionnaires from 150 patients with breast cancer who had been on hormone therapy at a hospital in Seoul. Data were analyzed with the t-test, ANOVA, and Pearson correlation coefficient to compare the degree of menopause symptoms by demographic, clinical and psychological factors. Results: The mean menopause symptoms score was $13.39{\pm}7.97$. Most participants reported having hot flushes and sweating (75.3%), physical and mental exhaustion (82.7%) and sexual problems (64.7%). Menopause symptoms and depression were correlated with each other (p<.01). Somato-vegetative symptoms were different significantly by age, menopausal status at time of operation, occupation and tumor. Psychological symptoms were different significantly by marital status, operation type and chemotherapy. Urogenital symptoms were different significantly by prior history of cancer, occupation, operation type and radiation therapy. Conclusion: These findings can be used to provide tailored nursing interventions by identifying high risk groups for menopausal symptom among breast cancer patients receiving hormone therapy.

키워드

참고문헌

  1. National Cancer Information Center. National cancer statistics 2014 [Internet].Gyeonggi:National Cancer Information Center; 2014 [cited 2017 January 5]. Available from: l.mbs/cancer/subview.jsp?id=cancer.
  2. Grunfeld EA, Hunter MS, Sikka P, Mittal S. Adherence beliefs among breast cancer patients taking tamoxifen. Patient Education Counseling. 2005;59(1):97-102. https://doi.org/10.1016/j.pec.2004.10.005
  3. Gotay C, Dunn J. Adherence to long-termadjuvant hormonal therapy for breast cancer. Expert Reviewof Pharmacoeconomics & Outcomes Research. 2011;11(6):709-715. http://dx.doi.org/10.1586/erp.11.80
  4. Hwang E, Yi M. Factors influencing quality of life in patients with breast cancer on hormone therapy. Journal of Korean Academy of Nursing. 2014;44(1):108-117. http://dx.doi.org /10.4040/jkan.2014.44.1.108
  5. Korean Breast Cancer Society. The breast. 2nd ed. Seoul: Ilchokak Publishing Co; 2005.
  6. Dorjgochoo T, Gu K, Kallianpur A, Zheng Y, Zheng W, Chen Z, et al. Menopausal symptoms among breast cancer patients 6 months after cancer diagnosis: a report from the Shanghai Breast Cancer Survival Study(SBCSS). Menopause. 2009;16(6):1205-1212. https://doi.org/10.1097/gme.0b013e3181aac32b
  7. Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV. Quality of life among long-term breast cancer survivors: a systematic review. European Journal of Cancer. 2005;41(17):2613-2619. https://doi.org/10.1016/j.ejca.2005.05.017
  8. Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA. Prevalence and treatment of menopausal symptoms among breast cancer survivors. Journal of pain and symptom management. 2002;23(6):501-509. https://doi.org/10.1016/S0885-3924(02)00395-0
  9. Korean Breast Cancer Society. Breast Cancer Facts & Figures 2016. Seoul: Korean Breast Cancer Society, 2016. p. 1-21.
  10. Ganz PA. Breast cancer, menopause, and long-termsurvivorship: critical issues for the 21st century. The American Journal of Medicine. 2005;118(12):136-141. https://doi.org/10.1016/j.amjmed.2005.09.047
  11. Fontaine C, Meulemans A, Huizing M, Collen C, Kaufman L, DeMey J, et al. Tolerance of adjuvant letrozole outside of clinical trials. The Breast. 2008;17(4):376-381. https://doi.org/10.1016/j.breast.2008.02.006
  12. Cappiello M, Cunningham RS, Knobf MT, Erdos D. Breast cancer survivors information and support after treatment. Clinical Nursing Research. 2007;16(4):278-293. https://doi.org/10.1177/1054773807306553
  13. Savard J, Simard S, Blanchet J, Ivers H, Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 2001;24(5):583-590. https://doi.org/10.1093/sleep/24.5.583
  14. Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN. Symptom cluster research: conceptual, design, measurement, and analysis issues. Journal of Pain and Symptom Management. 2006;31(1):85-95. https://doi.org/10.1016/j.jpainsymman.2005.05.015
  15. Byar KL, Berger AM, Bakken SL, Cetak MA. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncology Nursing Forum; 2006;33(1):18-26. https://doi.org/10.1188/06.ONF.E18-E26
  16. Avis NE, Crawford S, Manuel J. Psychosocial problems among younger women with breast cancer. Psycho-Oncology. 2004;13(5):295-308. https://doi.org/10.1002/pon.744
  17. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. Journal of Clinical Oncology. 2000;18(4):743-753. https://doi.org/10.1200/JCO.2000.18.4.743
  18. Yang YH. Trajectory of fatigue, quality of life and physical symptoms in cancer patients receiving radiotherapy. Journal of Korean Academy of Nursing. 2003;33(5):562-569. https://doi.org/10.4040/jkan.2003.33.5.562
  19. Vahdaninia M, Omidvari S, Montazeri A. What do predict anxiety and depression in breast cancer patients? A follow-up study. Social Psychiatry and Psychiatric Epidemiology. 2010;45(3):355-361. http://dx.doi.org/10.1007/s00127-009-0068-7
  20. Moon JM. Menopause symptoms, fatigue, and quality of life in post-chemotherapy breast cancer survivors [dissertation]. Seoul: Yonsei University. 2009. p. 1-108.
  21. Heinemann K, Ruebig A, Potthoff P, Schneider HP, Strelow F, Heinemann LA. The Menopause rating scale(MRS) scale: a methodological review. Health and quality of life Outcomes. 2004;2(1):1-8. https://doi.org/10.1186/1477-7525-2-1
  22. Gupta P, Sturdee DW, Palin SL, Majumder K, Fear R, Marshall T, et al. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric. 2006;9(1):49-58. https://doi.org/10.1080/13697130500487224
  23. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1(3):385-401. https://doi.org/10.1177/014662167700100306
  24. Cho MJ, Nam JJ, Suh GH. Prevalence of symptoms of depression in a nationwide sample of Korean adults. Psychiatry Research. 1998;81(3):341-352. https://doi.org/10.1016/S0165-1781(98)00122-X
  25. Bordeleau L, Pritchard K, Goodwin P, Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. Clinical Therapeutics. 2007;29(2):230-241. https://doi.org/10.1016/j.clinthera.2007.02.006
  26. Ganz PA, Greendale GA, Petersen L, Zibecchi L, Kahn B, Belin TR. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. Journal of the National Cancer Institute. 2000;92(13):1054-1064. https://doi.org/10.1093/jnci/92.13.1054
  27. Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric co-morbidity and management. International Journal of Methods in Psychiatric Research. 2003;12(1):34-43. https://doi.org/10.1002/mpr.140
  28. Cluze C, Rey D, Huiart L, BenDiane MK, Bouhnik AD, Berenger C, et al. Adjuvant endocrine therapywith tamoxifen in young women with breast cancer: determinants of interruptions vary over time. Annals of Oncology. 2012;23(4):882-890. https://doi.org/10.1093/annonc/mdr330
  29. Luber MP, Meyers BS, Williams-Russo PG, Hollenberg JP, DiDomenico TN, Charlson ME, et al. Depression and service utilization in elderly primary care patients. The American Journal of Geriatric Psychiatry. 2001;9(2):169-176. https://doi.org/10.1097/00019442-200105000-00009
  30. Mausbach BT, Schwab RB, Irwin SA. Depression as a predictor of adherence to adjuvant endocrine therapy(AET) in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Research and Treatment. 2015;152(2):239-246. http://dx.doi.org/10.1007/s10549-015-3471-7